PCR220 Patient-Reported Outcomes in LGMD 2E/R4, 2D/R3 and 2C/R5: Descriptive Analysis of Baseline PROMIS Data From the JOURNEY Natural History Study
Year: 2024
Type: conference-abstract
Source: Value in Health
Authors: I. Filipovic Audhya, A. Nacson, P. Fromy, K.L. Gooch, H. Stevenson
Institution: Sarepta Therapeutics (United States)
Language: English
Subfield: Genetics (clinical)
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W4405749685
